LAT in Biological Technology

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

... symptoms, non-inferiority relative to risperidone lat was not demonstrated. Safety findings in both tria...hizophrenia. Because of the delivery systems used, lat formulations may produce more consistent levels of...nted placebo (PP+Pbo) or flexible dose risperidone lat plus orally supplemented risperidone (LAT RIS+RIS)...